WKL Wolters Kluwer NV

Austin Regional Clinic Implements Wolters Kluwer’s UpToDate Anywhere for Streamlined Access to Clinical Decision Support within EMR

The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that Austin Regional Clinic (ARC) has implemented UpToDate® Anywhere, with easy access within the Epic electronic medical record (EMR) they use every day.

The integration helps deliver evidence-based information directly to the point of care. “Most of our team members feel that UpToDate is a gold standard source of information,” said Dr. Manish Naik, Chief Medical Information Officer and a member of the ARC Executive Board. “As long-time users of UpToDate, it was important to make access to UpToDate as easy as possible, so our clinicians can immediately get the answer to a clinical question while meeting with a patient. I use it regularly in my practice.”

Austin Regional Clinic is a multispecialty medical group that provides comprehensive healthcare services to more than 430,000 area residents, with 21 locations in seven cities throughout the greater Austin area.

“In the typical patient visit, physicians are expected to do so many tasks beyond patient care, such as considering meaningful use criteria and closing care gaps,” said Dr. Naik. “As we move further along the continuum of value-based care, we know that incorporating an authoritative clinical decision support resource within the clinical workflow is important to maintain high quality of care while eliminating unnecessary testing or treatment that lacks evidence-based support. Using the clinical guidelines with evidence in UpToDate helps support our efforts to improve quality metrics.”

Peter Bonis, MD, Chief Medical Officer, Clinical Effectiveness at Wolters Kluwer commented, “Embedding UpToDate into the Epic system saves clinicians time by eliminating unnecessary steps and clicks, providing the fastest possible access to diagnosis and treatment recommendations. This combination can help ARC’s healthcare professionals consistently and efficiently deliver the highest standards of care in the communities they serve.”

Follow UpToDate on Facebook, Twitter and LinkedIn.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

EN
28/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details August 14 – August 20, 2025

Share Buyback Transaction Details August 14 – August 20, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 14 – August 20, 2025 Alphen aan den Rijn – August 21, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 89,500 of its own ordinary shares in the period from August 14, 2025, up to and including August 20, 2025, for €10.1 million and at an average share price of €112.94. These repurchases are part of the share buyback program annou...

Wolters Kluwers: 1 director

A director at Wolters Kluwers maiden bought 1,875 shares at 131.520USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Share Buyback Transaction Details August 7 – August 13, 2025

Share Buyback Transaction Details August 7 – August 13, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 7 – August 13, 2025 Alphen aan den Rijn – August 14, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 137,900 of its own ordinary shares in the period from August 7, 2025, up to and including August 13, 2025, for €16.2 million and at an average share price of €117.75. These repurchases are part of the share buyback program announc...

 PRESS RELEASE

Share Buyback Transaction Details July 31 – August 6, 2025

Share Buyback Transaction Details July 31 – August 6, 2025 PRESS RELEASE                                         Share Buyback Transaction Details July 31 – August 6, 2025 Alphen aan den Rijn – August 7, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 109,700 of its own ordinary shares in the period from July 31, 2025, up to and including August 6, 2025, for €14.5 million and at an average share price of €132.48. These repurchases are part of the share buyback program announced on...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

CTP: Good results, continuation of strong demand dynamics. KBC: 2025 outlook, strong uplift post 2Q. RELX, Wolters Kluwer: Thomson Reuters 2Q25 results. SBM Offshore: Guidance up, one-offs play a role. Xior Student Housing: On track, continued focus on pricing and pipeline

ResearchPool Subscriptions

Get the most out of your insights

Get in touch